Literature DB >> 22765836

Effects on promoter activity of common SNPs in 5' region of GABRB3 exon 1A.

Miyabi Tanaka1, Julia N Bailey, Dongsheng Bai, Yumiko Ishikawa-Brush, Antonio V Delgado-Escueta, Richard W Olsen.   

Abstract

PURPOSE: The β3 subunit of the γ-aminobutyric acid type A receptors (GABA(A) -Rs) is an essential component of GABA(A) -Rs in fetal, perinatal, and adult mammalian brain. Various transcripts of the β3 subunit gene (GABRB3) produce various proteins with different N-termini. Rare variants in this N-terminus (exon 1A and exon 2) of GABRB3 protein segregate in affected family members of two multigeneration-multiplex families with remitting childhood absence epilepsy (rCAE), suggesting GABRB3 is a major Mendelian epilepsy gene for rare families with CAE. Therefore, the N-terminus of GABRB3 could be important for GABRB3 regulation in development, and its alteration could produce rCAE. Herein we determine if single nucleotide polymorphisms (SNPs) within the 1,148-bp region upstream from exon 1A influence the expression of GABRB3.
METHODS: We studied luciferase reporter expression for promoter activity, 1,148-bp upstream from exon 1A, using human embryonic kidney 293 cells. We generated constructs of the promoter region and compared different SNP haplotypes in 48 patients with rCAE. Next, we compared frequencies of rs20317, located in the core promoter region, and rs4906902, located in the enhancer region between 48 patients with rCAE and >500 healthy controls matched for ethnicity and ancestral origin. KEY
FINDINGS: Highest luciferase expression occurred 230-bp upstream of exon 1A. The construct that excluded this region lost luciferase activity. Therefore, this region contains the core promoter of exon 1A. Allele C but not allele G (rs20317) significantly increased luciferase expression activity. Allele C creates binding motifs for cMYB and EGR-3. Longer constructs overlapping this region have a binding motif for REST (RE1-silencing transcription factor), a critical epigenetic modulator for neuronal genes. REST represses expression of neuronal genes in nonneuronal tissues, resulting in reduced luciferase expression activity. Even in the suppressed condition, the longer construct enhanced luciferase expression activity of the shorter construct, which excluded the distal end containing rs4906902. However, allele frequencies of rs20317 and rs4906902 were not significantly associated with 48 rCAE patients in comparison to >500 controls matched for ethnicity and ancestral origin. SIGNIFICANCE: Common SNPs in the promoter region increase luciferase expression activity. An epigenetic modulator, REST, specifically alters expression of GABRB3 exon 1A transcripts, suggesting epigenetic regulation by REST dominantly controls the expression of GABRB3 variant 2 transcript in early life GABA(A) signaling. Abnormal epigenetic regulation could be involved in absence seizures. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22765836      PMCID: PMC3418397          DOI: 10.1111/j.1528-1167.2012.03572.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

Review 1.  The many faces of REST oversee epigenetic programming of neuronal genes.

Authors:  Nurit Ballas; Gail Mandel
Journal:  Curr Opin Neurobiol       Date:  2005-10       Impact factor: 6.627

2.  NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis.

Authors:  Z F Chen; A J Paquette; D J Anderson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

3.  A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity.

Authors:  Lydia Urak; Martha Feucht; Nahid Fathi; Kurt Hornik; Karoline Fuchs
Journal:  Hum Mol Genet       Date:  2006-07-11       Impact factor: 6.150

4.  Distinct profiles of REST interactions with its target genes at different stages of neuronal development.

Authors:  Yuh-Man Sun; Deborah J Greenway; Rory Johnson; Miyoko Street; Nikolai D Belyaev; Jim Deuchars; Thomas Bee; Sandra Wilde; Noel J Buckley
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

Review 5.  REST in good times and bad: roles in tumor suppressor and oncogenic activities.

Authors:  Sadhan Majumder
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

6.  15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.

Authors:  Amber Hogart; Raman P Nagarajan; Katherine A Patzel; Dag H Yasui; Janine M Lasalle
Journal:  Hum Mol Genet       Date:  2007-03-05       Impact factor: 6.150

Review 7.  Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues.

Authors:  F S Jones; R Meech
Journal:  Bioessays       Date:  1999-05       Impact factor: 4.345

8.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.

Authors:  Ewan Birney; John A Stamatoyannopoulos; Anindya Dutta; Roderic Guigó; Thomas R Gingeras; Elliott H Margulies; Zhiping Weng; Michael Snyder; Emmanouil T Dermitzakis; Robert E Thurman; Michael S Kuehn; Christopher M Taylor; Shane Neph; Christoph M Koch; Saurabh Asthana; Ankit Malhotra; Ivan Adzhubei; Jason A Greenbaum; Robert M Andrews; Paul Flicek; Patrick J Boyle; Hua Cao; Nigel P Carter; Gayle K Clelland; Sean Davis; Nathan Day; Pawandeep Dhami; Shane C Dillon; Michael O Dorschner; Heike Fiegler; Paul G Giresi; Jeff Goldy; Michael Hawrylycz; Andrew Haydock; Richard Humbert; Keith D James; Brett E Johnson; Ericka M Johnson; Tristan T Frum; Elizabeth R Rosenzweig; Neerja Karnani; Kirsten Lee; Gregory C Lefebvre; Patrick A Navas; Fidencio Neri; Stephen C J Parker; Peter J Sabo; Richard Sandstrom; Anthony Shafer; David Vetrie; Molly Weaver; Sarah Wilcox; Man Yu; Francis S Collins; Job Dekker; Jason D Lieb; Thomas D Tullius; Gregory E Crawford; Shamil Sunyaev; William S Noble; Ian Dunham; France Denoeud; Alexandre Reymond; Philipp Kapranov; Joel Rozowsky; Deyou Zheng; Robert Castelo; Adam Frankish; Jennifer Harrow; Srinka Ghosh; Albin Sandelin; Ivo L Hofacker; Robert Baertsch; Damian Keefe; Sujit Dike; Jill Cheng; Heather A Hirsch; Edward A Sekinger; Julien Lagarde; Josep F Abril; Atif Shahab; Christoph Flamm; Claudia Fried; Jörg Hackermüller; Jana Hertel; Manja Lindemeyer; Kristin Missal; Andrea Tanzer; Stefan Washietl; Jan Korbel; Olof Emanuelsson; Jakob S Pedersen; Nancy Holroyd; Ruth Taylor; David Swarbreck; Nicholas Matthews; Mark C Dickson; Daryl J Thomas; Matthew T Weirauch; James Gilbert; Jorg Drenkow; Ian Bell; XiaoDong Zhao; K G Srinivasan; Wing-Kin Sung; Hong Sain Ooi; Kuo Ping Chiu; Sylvain Foissac; Tyler Alioto; Michael Brent; Lior Pachter; Michael L Tress; Alfonso Valencia; Siew Woh Choo; Chiou Yu Choo; Catherine Ucla; Caroline Manzano; Carine Wyss; Evelyn Cheung; Taane G Clark; James B Brown; Madhavan Ganesh; Sandeep Patel; Hari Tammana; Jacqueline Chrast; Charlotte N Henrichsen; Chikatoshi Kai; Jun Kawai; Ugrappa Nagalakshmi; Jiaqian Wu; Zheng Lian; Jin Lian; Peter Newburger; Xueqing Zhang; Peter Bickel; John S Mattick; Piero Carninci; Yoshihide Hayashizaki; Sherman Weissman; Tim Hubbard; Richard M Myers; Jane Rogers; Peter F Stadler; Todd M Lowe; Chia-Lin Wei; Yijun Ruan; Kevin Struhl; Mark Gerstein; Stylianos E Antonarakis; Yutao Fu; Eric D Green; Ulaş Karaöz; Adam Siepel; James Taylor; Laura A Liefer; Kris A Wetterstrand; Peter J Good; Elise A Feingold; Mark S Guyer; Gregory M Cooper; George Asimenos; Colin N Dewey; Minmei Hou; Sergey Nikolaev; Juan I Montoya-Burgos; Ari Löytynoja; Simon Whelan; Fabio Pardi; Tim Massingham; Haiyan Huang; Nancy R Zhang; Ian Holmes; James C Mullikin; Abel Ureta-Vidal; Benedict Paten; Michael Seringhaus; Deanna Church; Kate Rosenbloom; W James Kent; Eric A Stone; Serafim Batzoglou; Nick Goldman; Ross C Hardison; David Haussler; Webb Miller; Arend Sidow; Nathan D Trinklein; Zhengdong D Zhang; Leah Barrera; Rhona Stuart; David C King; Adam Ameur; Stefan Enroth; Mark C Bieda; Jonghwan Kim; Akshay A Bhinge; Nan Jiang; Jun Liu; Fei Yao; Vinsensius B Vega; Charlie W H Lee; Patrick Ng; Atif Shahab; Annie Yang; Zarmik Moqtaderi; Zhou Zhu; Xiaoqin Xu; Sharon Squazzo; Matthew J Oberley; David Inman; Michael A Singer; Todd A Richmond; Kyle J Munn; Alvaro Rada-Iglesias; Ola Wallerman; Jan Komorowski; Joanna C Fowler; Phillippe Couttet; Alexander W Bruce; Oliver M Dovey; Peter D Ellis; Cordelia F Langford; David A Nix; Ghia Euskirchen; Stephen Hartman; Alexander E Urban; Peter Kraus; Sara Van Calcar; Nate Heintzman; Tae Hoon Kim; Kun Wang; Chunxu Qu; Gary Hon; Rosa Luna; Christopher K Glass; M Geoff Rosenfeld; Shelley Force Aldred; Sara J Cooper; Anason Halees; Jane M Lin; Hennady P Shulha; Xiaoling Zhang; Mousheng Xu; Jaafar N S Haidar; Yong Yu; Yijun Ruan; Vishwanath R Iyer; Roland D Green; Claes Wadelius; Peggy J Farnham; Bing Ren; Rachel A Harte; Angie S Hinrichs; Heather Trumbower; Hiram Clawson; Jennifer Hillman-Jackson; Ann S Zweig; Kayla Smith; Archana Thakkapallayil; Galt Barber; Robert M Kuhn; Donna Karolchik; Lluis Armengol; Christine P Bird; Paul I W de Bakker; Andrew D Kern; Nuria Lopez-Bigas; Joel D Martin; Barbara E Stranger; Abigail Woodroffe; Eugene Davydov; Antigone Dimas; Eduardo Eyras; Ingileif B Hallgrímsdóttir; Julian Huppert; Michael C Zody; Gonçalo R Abecasis; Xavier Estivill; Gerard G Bouffard; Xiaobin Guan; Nancy F Hansen; Jacquelyn R Idol; Valerie V B Maduro; Baishali Maskeri; Jennifer C McDowell; Morgan Park; Pamela J Thomas; Alice C Young; Robert W Blakesley; Donna M Muzny; Erica Sodergren; David A Wheeler; Kim C Worley; Huaiyang Jiang; George M Weinstock; Richard A Gibbs; Tina Graves; Robert Fulton; Elaine R Mardis; Richard K Wilson; Michele Clamp; James Cuff; Sante Gnerre; David B Jaffe; Jean L Chang; Kerstin Lindblad-Toh; Eric S Lander; Maxim Koriabine; Mikhail Nefedov; Kazutoyo Osoegawa; Yuko Yoshinaga; Baoli Zhu; Pieter J de Jong
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

9.  SOX5 controls the sequential generation of distinct corticofugal neuron subtypes.

Authors:  Tina Lai; Denis Jabaudon; Bradley J Molyneaux; Eiman Azim; Paola Arlotta; Joao R L Menezes; Jeffrey D Macklis
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

10.  Genome-wide identification of Smad/Foxh1 targets reveals a role for Foxh1 in retinoic acid regulation and forebrain development.

Authors:  Cristoforo Silvestri; Masahiro Narimatsu; Ingo von Both; Yongmei Liu; Nicholas B J Tan; Luisa Izzi; Peter McCaffery; Jeffrey L Wrana; Liliana Attisano
Journal:  Dev Cell       Date:  2008-03       Impact factor: 12.270

View more
  10 in total

1.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

2.  Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation.

Authors:  Ryan J Delahanty; Yanfeng Zhang; Terry Jo Bichell; Wangzhen Shen; Kelienne Verdier; Robert L Macdonald; Lili Xu; Kelli Boyd; Janice Williams; Jing-Qiong Kang
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

Review 3.  Tapping the Brakes: Cellular and Synaptic Mechanisms that Regulate Thalamic Oscillations.

Authors:  P Michelle Fogerson; John R Huguenard
Journal:  Neuron       Date:  2016-11-23       Impact factor: 17.173

4.  REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.

Authors:  Anantha L Marisetty; Li Lu; Bethany L Veo; Bin Liu; Cristian Coarfa; Mohamed Mostafa Kamal; Dina Hamada Kassem; Khushboo Irshad; Yungang Lu; Joy Gumin; Verlene Henry; Adriana Paulucci-Holthauzen; Ganesh Rao; Veerabhadran Baladandayuthapani; Frederick F Lang; Gregory N Fuller; Sadhan Majumder
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

5.  Meta-analysis of GABRB3 Gene Polymorphisms and Susceptibility to Autism Spectrum Disorder.

Authors:  Rezvan Noroozi; Mohammad Taheri; Soudeh Ghafouri-Fard; Zeinab Bidel; Mir Davood Omrani; Ali Sanjari Moghaddam; Parisa Sarabi; Alireza Mosavi Jarahi
Journal:  J Mol Neurosci       Date:  2018-07-18       Impact factor: 3.444

6.  The GABRB3 Polymorphism and its Association with Schizophrenia.

Authors:  Yi Liu; Xue-Fei Sun; Mei Ding; Yong-Ping Liu; Xi-Cen Zhang; Hao Pang; Jia-Xin Xing; Jin-Feng Xuan; Xi Xia; Bao-Jie Wang; Jun Yao
Journal:  J Mol Neurosci       Date:  2017-12-01       Impact factor: 3.444

7.  Identification of a sex-stratified genetic algorithm for opioid addiction risk.

Authors:  David Bright; Anna Langerveld; Susan DeVuyst-Miller; Claire Saadeh; Ashley Choker; Elisabeth Lehigh; Stephanie Wheeler; Ahed Zayzafoon; Minji Sohn
Journal:  Pharmacogenomics J       Date:  2021-02-15       Impact factor: 3.550

8.  Association analysis of GABRB3 promoter variants with heroin dependence.

Authors:  Chia-Hsiang Chen; Chia-Chun Huang; Ding-Lieh Liao
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  Functional analysis of haplotypes and promoter activity at the 5' region of the human GABRB3 gene and associations with schizophrenia.

Authors:  Yi Liu; Mei Ding; Yong-Ping Liu; Xi-Cen Zhang; Jia-Xin Xing; Jin-Feng Xuan; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  Mol Genet Genomic Med       Date:  2019-03-25       Impact factor: 2.183

10.  Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders.

Authors:  Chia-Hsiang Chen; Chia-Chun Huang; Min-Chih Cheng; Yen-Nan Chiu; Wen-Che Tsai; Yu-Yu Wu; Shih-Kai Liu; Susan Shur-Fen Gau
Journal:  Mol Autism       Date:  2014-06-25       Impact factor: 7.509

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.